• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物治疗骨关节炎和慢性下腰痛。

Opioid therapy for osteoarthritis and chronic low back pain.

机构信息

Department of Rheumatology and Immunology, David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA.

出版信息

Postgrad Med. 2010 Nov;122(6):87-97. doi: 10.3810/pgm.2010.11.2226.

DOI:10.3810/pgm.2010.11.2226
PMID:21084785
Abstract

BACKGROUND

Chronic low back pain (CLBP) and osteoarthritis (OA) of any joint are highly prevalent, occurring in > 50% of US adults aged ≥ 60 years. Opioids are prescribed more frequently for CLBP and OA than for any other noncancer pain, and the judicious use of opioids is recommended by treatment guidelines for the management of CLBP and OA pain.

OBJECTIVE

To review the appropriate role of opioid analgesics in the treatment of patients with moderate-to-severe pain due to CLBP or OA and provide recommendations for best practices when prescribing opioids.

METHODS

Articles were identified through a search of PubMed. Additional references were identified for inclusion from the reference lists of articles identified via the literature search, treatment guidelines, and Cochrane Reviews.

RESULTS

The available data suggest that opioid therapy represents a valuable treatment option in patients who do not respond to other analgesics and in whom the potential benefits of treatment outweigh the potential risks. Prescribing physicians need to perform vigilant patient screening and monitoring for signs of abuse, intervene promptly to manage or prevent adverse events and drug interactions, tailor opioid therapy to individual patients' comorbidities, and know how to switch or rotate opioids to find the best treatment option.

CONCLUSIONS

Prescribers need to understand the place of opioid therapy in a multimodal treatment program that includes patient rehabilitation to reduce pain and improve function. The analgesic benefits of opioids must be balanced against concerns about addiction and abuse, adverse events, and their potential impact on other aspects of treatment.

摘要

背景

慢性下背痛(CLBP)和任何关节的骨关节炎(OA)的患病率都很高,超过 50%的美国≥60 岁成年人患有这些疾病。与任何其他非癌症疼痛相比,阿片类药物更常被用于治疗 CLBP 和 OA,并且治疗指南建议谨慎使用阿片类药物来治疗 CLBP 和 OA 疼痛。

目的

回顾阿片类镇痛药在治疗 CLBP 或 OA 引起的中重度疼痛患者中的适当作用,并为阿片类药物处方提供最佳实践建议。

方法

通过在 PubMed 中进行搜索来确定文章。从通过文献检索、治疗指南和 Cochrane 综述确定的文章的参考文献列表中确定了其他参考文献以供纳入。

结果

现有数据表明,对于对其他镇痛药无反应且治疗的潜在益处超过潜在风险的患者,阿片类药物治疗代表了一种有价值的治疗选择。开处方的医生需要对患者进行仔细的筛查和监测,以发现滥用迹象,及时干预以管理或预防不良事件和药物相互作用,根据患者的合并症调整阿片类药物治疗,并了解如何切换或轮换阿片类药物以找到最佳治疗选择。

结论

开处方的医生需要了解阿片类药物治疗在包括患者康复在内的多模式治疗方案中的作用,以减轻疼痛和改善功能。必须权衡阿片类药物的镇痛益处与成瘾和滥用、不良事件及其对治疗其他方面的潜在影响相关的担忧。

相似文献

1
Opioid therapy for osteoarthritis and chronic low back pain.阿片类药物治疗骨关节炎和慢性下腰痛。
Postgrad Med. 2010 Nov;122(6):87-97. doi: 10.3810/pgm.2010.11.2226.
2
Further qualification of a therapeutic responder index for patients with chronic low back pain.慢性腰痛患者治疗反应指数的进一步确证。
J Rheumatol. 2011 Feb;38(2):362-9. doi: 10.3899/jrheum.091444. Epub 2010 Nov 1.
3
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain.盐酸他喷他多缓释片治疗慢性骨关节炎疼痛和腰痛的疗效和安全性。
Adv Ther. 2010 Jun;27(6):381-99. doi: 10.1007/s12325-010-0036-3. Epub 2010 Jun 11.
4
Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.在开始使用特定药物治疗骨关节炎患者后,治疗转换、增效和停药的模式。
Clin Ther. 2011 Dec;33(12):1914-31. doi: 10.1016/j.clinthera.2011.10.019. Epub 2011 Nov 14.
5
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
6
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain.盐酸曲马多缓释片治疗慢性腰痛或骨关节炎疼痛的长期安全性和耐受性。
Pain Pract. 2010 Sep-Oct;10(5):416-27. doi: 10.1111/j.1533-2500.2010.00397.x.
7
Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.用于治疗慢性下腰痛的羟吗啡酮缓释剂:根据年龄、性别和既往阿片类药物使用情况分层的富集入组临床试验数据的回顾性汇总分析
Clin Ther. 2009 Feb;31(2):347-59. doi: 10.1016/j.clinthera.2009.02.019.
8
An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system.一项关于接受芬太尼透皮贴剂治疗的慢性下腰痛患者健康相关生活质量和疼痛结局的观察性研究。
Curr Med Res Opin. 2005 Jun;21(6):849-62. doi: 10.1185/030079905X46377.
9
Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings.在社区环境中,骨关节炎和慢性下背痛患者的处方药和替代疗法的使用和费用。
Pain Pract. 2012 Sep;12(7):550-60. doi: 10.1111/j.1533-2500.2012.00532.x. Epub 2012 Feb 5.
10
Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.Remoxy®(盐酸羟考酮控释片)治疗中重度慢性骨关节炎或腰痛患者的长期安全性。
Pain Med. 2011 May;12(5):755-60. doi: 10.1111/j.1526-4637.2011.01100.x. Epub 2011 Apr 11.

引用本文的文献

1
Virtual reality-based therapy for chronic low back and neck pain: a systematic review with meta-analysis.基于虚拟现实的慢性腰颈疼痛治疗:一项荟萃分析的系统评价
EFORT Open Rev. 2024 Jul 1;9(7):685-699. doi: 10.1530/EOR-23-0197.
2
Evaluating the association between opium abuse, blood lead levels, and the complexity of coronary artery disease.评估阿片类药物滥用、血铅水平与冠状动脉疾病复杂性之间的关联。
Physiol Rep. 2024 Mar;12(5):e15975. doi: 10.14814/phy2.15975.
3
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis.
中重度骨关节炎治疗的多方法定量获益-风险评估。
Br J Clin Pharmacol. 2022 Aug;88(8):3837-3846. doi: 10.1111/bcp.15309. Epub 2022 Apr 8.
4
Effectiveness and tolerability of tapentadol prolonged release compared with prior opioid therapy for the management of severe, chronic osteoarthritis pain.与之前的阿片类药物治疗相比,曲马多缓释片在治疗严重慢性骨关节炎疼痛方面的有效性和耐受性。
Clin Drug Investig. 2013 Sep;33(9):607-19. doi: 10.1007/s40261-013-0102-0.
5
Medical and psychological risks and consequences of long-term opioid therapy in women.女性长期使用阿片类药物治疗的医学和心理风险及后果。
Pain Med. 2012 Sep;13(9):1181-211. doi: 10.1111/j.1526-4637.2012.01467.x. Epub 2012 Aug 20.
6
Duloxetine in the management of chronic musculoskeletal pain.度洛西汀治疗慢性肌肉骨骼疼痛。
Ther Clin Risk Manag. 2012;8:267-77. doi: 10.2147/TCRM.S17428. Epub 2012 Jun 19.